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2ABSTRACT24
Two-day-old (P2), but not nine-day-old (P9), rat pups are susceptible to systemic25
infection following gastrointestinal colonization by Escherichia coli K1. Age dependency26
reflects the capacity of colonizing K1 to translocate from gastrointestinal (GI) tract to27
blood. A complex GI microbiota developed by P2, showed little variation over P2-P9 and28
did not prevent stable K1 colonization. Substantial developmental expression was29
observed over P2-P9, including up-regulation of genes encoding components of the small30
intestinal (α-defensins Defa24 and Defa-rs1) and colonic (trefoil factor Tff2) mucus31
barrier. K1 colonization modulated expression of these peptides: developmental32
expression of Tff2 was dysregulated in P2 tissues and was accompanied by a decrease in33
mucin Muc2. Conversely, α-defensin genes were up-regulated in P9 tissues. We propose34
that incomplete development of the mucus barrier during early neonatal life and the35
capacity of colonizing K1 to interfere with mucus barrier maturation provide36
opportunities for neuropathogen translocation into the bloodstream.37
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3INTRODUCTION47
The newborn infant is particularly vulnerable to systemic bacterial infection during the48
first four weeks of life and mortality and morbidity associated with neonatal bacterial49
meningitis (NBM) and accompanying sepsis remain significant despite advances in50
antibacterial chemotherapy and supportive care (1, 2). In the developed world,51
Escherichia coli and Group B streptococci are responsible for the majority of cases of52
NBM and bacteria isolated from the cerebrospinal fluid of infected neonates invariably53
elaborate a protective polysaccharide capsule. Of neuroinvasive E. coli isolates, 80-85%54
express the K1 capsule (3, 4), a homopolymer of α-2,8-linked polysialic acid (polySia)55
that mimics the molecular structure of the polySia modulator of neuronal plasticity in56
mammalian hosts (5) and enables these strains to evade detection by a neonatal innate57
immune system undergoing a process of age-dependent maturation (6).58
Risk factors for NBM include obstetric and perinatal complications, premature birth59
and low birth weight, particularly in low socioeconomic groups (7), but predisposition to60
infection is critically dependent on vertical transmission of the causative agent from the61
mother to infant at, or soon after, birth (8). Although many aspects of the pathogenesis of62
E. coli K1 in NBM are unclear, maternally-derived E. coli K1 bacteria are known to63
colonize the neonatal gastrointestinal (GI) tract (8, 9, 10), which is sterile at birth but64
rapidly acquires a complex microbiota that eventually converges toward a profile65
characteristic of the adult GI tract (11). E. coli K1 bacteria then translocate from the66
lumen of the small intestine or colon into the systemic circulation before entering the67
CNS across the blood-brain barrier at the cerebral microvascular endothelium of the68
4arachnoid membrane (12) or the blood-cerebrospinal fluid (CSF) barrier at the choroid69
plexus epithelium (13).70
Many of the temporal and spatial aspects of NBM can be reproduced in a rodent71
model of E. coli K1 infection initially developed by Glode et al. (14) and subsequently72
refined by others (15, 16). Thus, oral (15, 16, 17) or intragastric (14, 18) administration of73
E. coli K1 results in stable and persistent GI colonization of adults and neonates. E. coli74
K1-colonized neonatal rat pups, but not adult animals, subsequently develop lethal75
systemic infection, with E. coli K1 present in the blood circulation and brain tissue (15,76
19, 20). Persistence of bacteria in the blood is dependent on the continued expression of77
the polySia capsule, as evidenced by the inability of capsule defective mutants to cause78
systemic infection (21) and by the capacity of intraperitoneally delivered capsule-79
selective depolymerase to abrogate infection (16). Bacteria enter the CSF compartment of80
infected rat pups predominantly at the choroid plexus and penetrate superficial brain81
tissue (19), where they induce inflammation via proinflammatory cytokine-induced82
pathways involving IL-1β, IL-6 and TNF-α (20).83
The experimental rodent model of infection has yielded fresh insights into the transit84
of the E. coli K1 neuropathogen from the blood circulation into the CNS; in particular,85
the age-dependency of experimental NBM in rodents is striking, with clear evidence of86
systemic infection at two days of age. We now employ this model to shed light on the87
mechanism of bacterial translocation from the GI tract to the blood compartment. As it is88
unlikely that conventional prophylactic measures such as vaccination can be readily89
implemented to prevent infection in the at-risk neonatal cohort - the poor immunogenicity90
of polySia, the relative unresponsiveness of the neonatal immune system, lack of IgA-91
5mediated protection of mucosal surfaces and the age profile of the target patient92
population mitigate against the successful development of vaccination as a preventative93
strategy for the control of E. coli NBM (22, 23) – a more detailed understanding of the94
early stages of NBM will underpin alternative approaches to the prevention of E.coli K195
systemic neonatal infection, such as bacteriophage-mediated selective elimination of the96
E. coli K1 bacterial cohort from maternal or neonatal reservoirs, and forms the basis of97
the study reported here.98
The preterm rodent GI tract is sterile but becomes colonized immediately after birth99
(24). Little is known of the dynamics of colonization of the rat GI tract by maternally-100
derived microbes but any lag in the development of a mature microbiota may allow101
colonizing E. coli K1 to achieve sufficient density in the colon or small intestine to102
permit entry into the blood circulation during the first few days of life. K1 bacteria transit103
to the blood from the GI tract via the mesenteric lymph nodes and there is compelling104
evidence that they do so with a very low frequency (15). In the study reported here, we105
found no evidence that the development of a mature microbiota in neonatal rat pups106
influenced the size or location within the GI tract of the colonizing E. coli K1 population107
and is unlikely to be responsible for the strong age-dependency of experimental NBM in108
rodents. There were, however, differences in the appearance of the GI tract between109
susceptible and non-susceptible animals; tissues of younger, susceptible pups contained110
fewer goblet cells and the intestinal mucus layer was less developed in comparison to111
older, resistant animals. We also identified major differences in the capacity of112
susceptible and non-susceptible neonatal pups to respond to GI tract colonization by E.113
coli K1, potentially enabling a closer association of E. coli K1 with the epithelial surface114
6in susceptible compared to non-susceptible pups. Further, susceptible rat pups, in contrast115
to non-susceptible animals, were unable to respond to E. coli K1 colonization by116
increasing the concentrations of the defensin peptides Defa-rs1 and Defa24 in the lumen117
of the small intestine. These changes were not evident following GI tract colonization by118
non-pathogenic E. coli K12. We propose a model based on these observations to account119
for the strong age-dependency of E. coli K1 NBM.120
121
MATERIALS AND METHODS122
Bacterial strains and bacterial colonization of neonatal rat pups. E. coli O18:K1123
strain A192PP was derived from E. coli A192, an isolate from a patient with septicemia124
(25), by serial passage through neonatal rat pups as described previously (16, 19); the125
passaged strain was significantly more virulent for rat pups than E. coli A192 (17). E. coli126
K12 was obtained from the Coli Genetic Stock Center, Yale University as CGSC5073127
(K12 wildtype). Wistar rat litters (9-14 individuals), obtained from Harlan UK, were128
retained in a single cage with their natural mothers after birth. For GI tract colonization,129
all members of a litter were fed 20 μl of mid-exponential phase Mueller-Hinton (MH)130
broth culture of E. coli K1 (2-6 x 106 CFU, warmed to 37oC) from an Eppendorf131
micropipette. Colonization was determined by MacConkey agar culture of perianal swabs132
as described earlier (16). Bacteremia was detected by culture on MacConkey agar of133
daily blood samples taken from superficial veins in the footpad. Animal experiments134
were approved by the Ethical Committee of UCL School of Pharmacy and the UK Home135
Office (HO) and were conducted under HO Project Licence PPL 80/2243.136
137
7Processing of animal material. Stools were collected from adult animals and neonates138
were killed by decapitation; post mortem the neonatal GI tract, from stomach to colon,139
was excised aseptically. For E. coli K1 enumeration and DNA extraction, samples were140
transferred to 2 ml ice-cold PBS and homogenized. For enumeration, the homogenate141
was serially diluted in PBS and plated onto MacConkey agar. Coliform colonies were re-142
streaked and assayed for sensitivity to the K1-specific lytic phage K1E (26). DNA was143
extracted from homogenates using the QIAamp Stool DNA Mini Kit (Qiagen). For RNA144
extraction, tissues were transferred to RNAlater (Ambion) and stored overnight at 4°C.145
RNA was then extracted using the RNeasy Midi Kit (Qiagen). Nucleic acid extractions146
were quantified and assessed for purity using a Nanodrop 1000 (Thermo Scientific) and147
native DNA/RNA agarose gel electrophoresis. For protein extraction, tissues were148
homogenized in 2 ml tissue lysis buffer containing 1% v/v NP-40, 1% v/v Tween-20 and149
Tris-EDTA (10mM Tris-HCl, 1mM EDTA, pH 7.4) in PBS supplemented with 1 x150
Complete Mini EDTA-free protease inhibitor cocktail (Roche). Protein extracts were151
quantified using Bio-Rad Protein Assay reagent in cuvette format. All homogenizations152
were performed on ice using an Ultra-Turrax T-10 homogenizer (IKA Werke); extracts153
were stored at -80°C prior to analysis.154
155
GI microbiota profiles156
Analysis of the composition of complex microbial communities has been facilitated by an157
expanding database of small subunit rRNA gene (SSU rDNA) sequences. Palmer et al.158
(11, 27) designed a microarray-based platform incorporating probes which target the159
more variable SSU rDNA regions; the customized microarray (Agilent Technologies),160
8used in the current study, consisted of 10,266 unique oligonucleotide sequences covering161
1,590 bacterial and 39 archeal species as well as 649 higher order taxonomic groups162
which together ensure broad coverage of known SSU rDNA sequences within the163
prokaryotic multiple sequence (prokMSA) database (http://greengenes.lbl.gov/cgi-164
bin/nph-index.cgi). The platform can be used to quantify different SSU rDNA165
populations from mixed samples using standard microarray technology. DNA was166
extracted from three stool samples for each adult and three GI tissue samples per litter for167
each neonatal age group examined using the QIAamp Stool DNA mini kit. SSU rDNA168
was amplified from 1 μg extracted DNA using the GoTaq Green PCR kit (Promega) and169
the broad-range bacteria-specific primers Bact-8F and T7-1391R described by Palmer et170
al. (11). Amplified DNA was quantified using a Nanodrop 1000 and the products171
confirmed by agarose gel electrophoresis. A reference pool was constructed from an172
equimolar mixture of all samples for use as a template for in vitro transcription.173
Reference pool amplicons were labeled with Cy3 and test samples comprising amplified174
DNA from animals in individual age groups with Cy5 using the gDNA labeling kit plus175
(Agilent Technologies); combined Cy3/5 labeled samples were purified using MinElute176
columns (Qiagen). For hybridization, 4.5 µl blocking agent and 22.5 µl hybridisation177
buffer from Hyb kit (Agilent Technologies) were added to 18 µl of eluted DNA. After 3178
min at 95oC and 30 min at 37oC, the 45 µl sample was loaded into a hybridization179
chamber (Agilent Technologies) and the arrays hybridized at 65oC in a rotating oven for180
24 h. Slides were washed in Oligo aCGH wash buffers (Agilent Technologies) according181
to the manufacturer’s instructions. Microarrays were scanned using an Agilent high182
resolution C scanner at a 5 µm resolution with the extended dynamic range setting at 100183
9& 10. Microarray images were processed using feature extraction software v9.5.1.1184
(Agilent Technologies) utilising linear normalization and rank consistent probe dye185
normalization methods. Data was processed using GeneSpring GX v7.3.1 (Agilent186
Technologies) to combine data from replicate spots and multiple node/species reporters.187
Test samples were normalized to adult control samples to give an estimate of relative188
abundance.189
190
Histology and immunohistochemistry. Segments of proximal, mid- and distal small191
intestine were removed from P2 and P9 pups without washing; segments of whole colon192
was removed from P2 animals and colon from P9 pups was divided into proximal and193
distal portions, again without washing. Tissues were placed in methanol-Carnoy’s194
fixative and maintained at room temperature for at least 3 h. Paraffin-embedded sections195
were dewaxed and hydrated; mucin was visualized using anti-MUC2C3 antiserum with196
Alexa 546-conjugated rabbit immunoglobulins (Life Technologies). Immuno-stained197
sections were mounted in Prolong Anti-fade (Life Technologies). Images were obtained198
at room temperature using a Nikon Eclipse E1000 fluorescence microscope with a Plan-199
Fluor 20x/0.50 DIC M or a 10x/0.30 DIC L objective (Nikon). Images were acquired200
with a Nikon Digital sight DS5M camera and the Nikon Eclipse E1000 control software.201
Further processing was performed with Adobe Photoshop software. All image202
adjustments were performed equally for all comparably stained images.203
204
Quantitative PCR. qPCR was used to amplify and quantify DNA from the bacterial205
components of the GI tract microbiota; a qPCR assay was developed to enumerate E.206
10
coli K1 in the GI tract. The bacterial load was quantified by amplification of 16S rDNA207
essentially according to Palmer et al (11). Briefly, universal forward primer 8FM (0.9208
µM) and Bifidobacterium longum forward primer 8FB (0.09 µM) were used in209
conjunction with universal reverse primer Bact515R (0.9 µM). The thermal cycling210
program comprised 95°C for 3 min, then 40 cycles of 95°C for 20 s, 55°C for 20 s, 60°C211
for 35 s, 65°C for 15 s and 72°C for 15 s. E. coli K1 was quantified, using a method212
validated in this study (Supplemental data; Appendix 1), by amplification of the K1-213
specific gene neuS (28). Forward primer neuSF3 (0.625 µM) was used in conjunction214
with reverse primer neuSR3 (0.625 µM). The E. coli K1 thermal cycling program215
comprised 95°C for 3 min, then 40 cycles of 95°C for 20 s and 61°C for 20 s. In both216
assays, each 20 µl reaction comprised 1 x Brilliant III SYBR Green Ultra-Fast QPCR217
Mastermix (Agilent), the assay-specific primers, Rox reference dye (30 nM) and 5 µl218
extracted DNA. Reactions were performed using a Mx3000P instrument (Stratagene) and219
fluorescence data for SYBR1 and Rox acquired at the annealing step of each cycle.220
Tenfold serial dilutions of triplicate genomic DNA extractions from known quantities of221
E. coli strains A192PP (for the E. coli K1 assay), and CGSC5073 (for assay of total222
bacteria) were used to generate standard curves for each qPCR reaction plate. The223
abundance of neuS or 16S rDNA was calculated based on these standard curves using224
Mx3000P v2.0 software (Stratagene) to normalize SYBR1 to Rox fluorescence and to225
determine cycle threshold values using adaptive baseline and amplification-based226
threshold algorithm enhancements. qPCR reaction plates were run in duplicate and227
contained duplicate standard, sample and no-template control reactions.228
229
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Semi-quantitative RT-PCR. cDNA was amplified from RNA extracts by one-step RT-230
PCR and amplicons resolved by agarose gel electrophoresis. RT-PCR reactions were231
prepared in a C2BSC to reduce the risk of contamination. RNA (50 ng) was mixed with232
Brilliant II RT-PCR master mix (Agilent), gene-specific forward and reverse primer pairs233
(0.5 μM each) and AffinityScript RT/RNase block enzyme mixture (Agilent) to a final234
reaction volume of 25 μL. Control reactions without RNA template or RT/RNase block235
enzyme were also prepared. RT-PCR was performed using a thermocycling program of236
30 min at 50°C and 10 min at 95°C, followed by 35 cycles of 30s at 95°C, 1 minute at237
60°C and 30 s at 72°C. Reactions were mixed with 5 μL of 6 x Gel Loading Buffer238
(0.05% w/v bromophenol blue, 40% w/v sucrose, 0.1 M pH 8 EDTA, 0.5% w/v SDS) and239
resolved by agarose gel electrophoresis. Gels were visualized using a Molecular Imager240
FX system (Bio-Rad) set to detect UV fluorescence.241
242
Gene expression analysis. RNA was extracted from GI tissues using Qiagen RNeasy243
Animal Tissue Midi Kit (Qiagen). RNA integrity and concentration were determined with244
a NanoDrop 1000 (Thermo Scientific). Labeled cDNA was hybridised to Affymetrix245
GeneChip Rat Genome 230 2.0 arrays. The arrays comprised over 31,000 probe sets246
representing variants from greater than 28,000 rat genes; there are eleven probe sets247
represented for each coding sequence. GeneChip expression analysis was performed248
using samples extracted from uninfected rat pups of age comparable to the reference249
control. Labeled cDNA synthesis, fragmentation, hybridisation, washing and scanning of250
rat genome arrays were performed according to the Affymetrix GeneChip Expression251
Analysis Technical Manual (702232; Rev. 2). Hybridizations were incubated for 16 h at252
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45ºC. GeneChips were scanned using Affymetrix Gene Array Scanner 3000.253
Hybridisation data was analysed on GeneChip Operating Software (GCOS v1.4). DAT,254
CEL and CHP files were removed using the Data Transfer Tool (v1.1.1); CEL files were255
imported into the third-party data analysis software GeneSpring v7.3 (Agilent256
Technologies). GC-RMA normalisation was performed on all data generated using a chip257
from a comparable uninfected rat pup as reference.258
259
Competitive ELISA for Tff2. Goat polyclonal anti-Tff2 primary antibody (sc-23558;260
Santa Cruz Biotechnology) was biotinylated, diluted 1:1,000 in blocking buffer (1 % w/v261
casein in Tris-buffered saline), dispensed in 100 μl aliquots and 10 μg of tissue protein262
extract added. Serial twofold dilutions of a15 ng/ml PBS solution of recombinant human263
Tff2 (rhTff2; Sigma Aldrich) were prepared and 100 μl of each dilution added to264
individual tubes to give a standard range of 1500-23.4 pg rhTff2. Control tubes265
containing only anti-Tff2 antibody were also prepared. Standard/antibody,266
sample/antibody and control tubes were incubated with rotation for 6 h at 20oC.267
Separately, aliquots (0.1 μg in 100 μl bicarbonate/carbonate buffer pH 9.6) of rhTff2268
were transferred to each well of 96-well Maxisorp Immunoplates (Nunc), incubated with269
rotation at 20oC for 2 h, buffer aspirated and wells washed twice with 0.05% v/v270
Tween20 in PBS. Wells were blocked with 350 μl of blocking buffer, incubated for 2 h,271
buffer aspirated and the wells washed twice.272
Standard/antibody, sample/antibody and control solutions were applied to individual273
wells and plates incubated for 16 h at 20oC. Antibody solutions were aspirated and wells274
washed four times. HRP-streptavidin conjugate (0.5 μg in 100μl PBS; Vector Labs) was275
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applied to each well, the plates incubated for 1 h, supernatants removed and wells washed276
four times. Plates were developed by addition of 100 μl of 3,3',5,5'-tetramethylbenzidine277
liquid substrate and incubated in the dark for 15-30 min. Color development was278
terminated by the addition of 100 μl 0.4 M sulfuric acid. OD450 was measured using a279
SPECTROstar Omega plate-reader (BMG Labtech) and Tff2 quantified by comparison to280
standard curves obtained by plotting the OD450 values against the amount of rhTff2281
incubated with anti-Tff2 IgG. All standard, sample and control wells were run in282
triplicate on each plate and each plate was duplicated.283
284
Serum cytokine assays. Serum was obtained by centrifugation (1500 x g; 10 min) of285
blood collected from culled neonatal rats. Levels of IL-1β and IL-6 were determined by286
sandwich ELISA assays, utilising, respectively, rabbit or goat polyclonal cytokine-287
specific capture and biotinylated detection antibodies and recombinant rat cytokine288
standards from an appropriate ELISA Development Kit (Peprotech). Reactions were289
developed by incubation with streptavidin-HRP conjugate (Vector Labs) for 30 min290
followed by incubation with 3,3',5,5'-tetramethylbenzidine. Reactions were terminated291
after 15 min by addition of 0.5 M H2SO4 and A450nm measured using a SPECTROstar292
plate-reader (BMG Labtech). All assays were performed in triplicate in 96-well293
MaxiSorp immunoplates (Nunc).294
295
Extraction of tissue cell nuclear proteins. Prior to extraction of nuclear proteins, single296
cell suspensions were obtained from whole tissue samples. Tissues were washed in 2 ml297
ice-cold PBS then transferred to 4.7 ml HEPES buffer (10 mM HEPES, 150 mM NaCl, 5298
14
mM KCl, 1 mM MgCl2, 1 mM CaCl2) supplemented with collagenase (2 mg/ml) and299
DNase I (80 U/ml). Samples were homogenized for 10 s on ice, incubated at 37°C for 30300
min and homogenized for 10 s. Homogenates were filtered (100 µm Cell Strainer; BD301
Falcon) and tissue cells recovered by centrifugation (500 x g; 10 min). Cell pellets were302
suspended in 5 ml nuclear extraction buffer (0.32 M Sucrose, 10 mM Tris-HCl, 3mM303
CaCl2, 2 mM MgOAc, 0.1 mM EDTA, 1 mM DTT) supplemented with 0.5% v/v NP-40304
to lyse the plasma membrane, followed by centrifugation (500 x g; 5 min) to obtain305
nuclei. After aspiration of the cytoplasmic protein fraction, nuclei were washed twice in306
nuclear extraction buffer and recovered by centrifugation (500 x g; 5 min). Nuclei were307
suspended in 1.5 ml low salt buffer (20 mM HEPES, 1.5 mM MgCl2, 20 mM KCl, 0.2308
mM EDTA, 25% v/v glycerol, 0.5 mM DTT) and lysed by the gradual addition of an309
equal volume of high salt buffer (20 mM HEPES, 1.5 mM MgCl2, 800 mM KCl, 0.2 mM310
EDTA, 25% v/v glycerol, 0.5 mM DTT, 1% v/v NP-40). Samples were incubated for 45311
min at 4°C on a rotator then centrifuged (14000 x g; 15 min). The nuclear protein fraction312
was aspirated and stored at -80°C prior to analysis. All nuclear protein extraction buffers313
were supplemented with 1 x Complete Mini EDTA-free protease inhibitor cocktail314
(Roche).315
316
NF-κB electrophoretic mobility shift assay. A fluorophore-labeled double stranded317
oligonucleotide probe containing the NF-κB consensus binding site was prepared by318
annealing equimolar volumes of 5’-Cy5 conjugated sense and antisense single stranded319
oligonucleotides at room temperature for 10 min. Binding reaction mixtures were320
prepared from 1 µl poly-dIdC (1 mg/ml), 3 µl 5 x binding buffer (50 mM Tris-HCl, 750321
15
mM KCl, 2.5 mM EDTA, 0.5% v/v Triton X-100, 62.5% v/v glycerol, 1 mM DTT), 5 µg322
nuclear protein extract, 1 µl labeled probe (10 ng/µl) and ddH2O in a total volume of 15323
µl. Reaction mixtures were incubated at room temperature for 30 min prior to324
electrophoresis on 5 % v/v polyacrylamide gels. Cy5 fluorescence was detected using a325
Molecular Imager FX scanner (Bio-Rad).326
327
RESULTS328
Translocation of E. coli K1 to the blood compartment and capacity to cause lethal329
infection is dependent on the age of the colonized host. The septicemia isolate E. coli330
A192 efficiently colonized the GI tract of neonatal rat pups (frequency of 100%) but only331
23% (17) to 35% (15) of colonized pups progressed to the bacteremic state. We therefore332
enhanced the capacity of the A192 strain to translocate to the blood compartment by two333
rounds of serial passage in neonatal rats. Bacteria recovered from the blood following334
passage produced bacteremia at higher frequency (100% of colonized pups); one colony335
from blood culture was propagated for further experimentation and designated strain336
A192PP. Feeding of E. coli A192PP to two-day-old (P2) pups resulted in 100%337
colonization of the GI tract within 24-48 h; 48 h after dosing, E. coli K1 began to appear338
in the bloodstream and by day 7 all animals had succumbed to a lethal bacteremia (Fig.339
1A). P5 pups were less susceptible to infection, with, typically, around 50% of animals340
displaying bacteremia following GI tract colonization rates of 100%. P9 animals were341
efficiently colonized by A192PP but were refractory to bacteremia and lethal infection342
(Fig. 1A). Patterns of colonization and infection were highly reproducible in Wistar rat343
pup litters. For practical reasons, fecal material could only be sampled from the perianal344
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area and the colonization lag displayed in Fig. 1A is likely to be due to increasing345
contamination of this anatomical region (engendering an increasingly large coliform346
population) over the first week of life. There was an age-dependent decrease in347
susceptibility to lethal infection over the P2 to P9 period (Fig. 1B); pups began to acquire348
resistance from day 3 and were completely resistant by day 9. Reductions in349
susceptibility to infection following colonization will be accompanied by structural,350
physiological and microbiological changes of GI tract tissues (29, 30) and we therefore351
undertook parallel histological and immunohistochemical investigations of GI tissue in352
order to ensure that processes that affect susceptibility to infection can be correlated with353
the dynamic process of postnatal development of the rat intestine. Over the P2 to P9354
period, the length of the digestive system (stomach to colon) increased in incremental355
fashion from a mean of 25.6 cm at P2 to 47.6 cm at P9 and was characterized by rapid356
postnatal physiological and anatomical development due to expansion of the small357
intestine and increased differentiation of the cecum (Fig. 1C). As is evident from Alcian358
blue/PAS stained sections of intestinal tissue from pups over the P2-P9 period (Fig. 2),359
organ maturation was accompanied by increases in the thickness of the submucosal layer360
and the number of mucin-containing cells. In accord with others (31), we found no361
histological evidence for any lack of structural integrity during the early phases of362
neonatal development. No discernable histological changes occurred 24 h and 48 h after363
colonization of P2 and P9 pups with A192PP.364
365
Systemic infection is unrelated to either the size of the colonizing E. coli K1 cohort366
or the composition of the GI tract microbiota. Translocation of E. coli K1 from the367
17
neonatal rat GI tract to the blood occurs via the mesenteric lymph nodes and each368
bacterial cell has a low probability of overcoming the mechanical and immunological369
barriers to gain access to the blood compartment (15), even though neonatal intestinal370
mucosal barriers may be incompletely developed at birth (32). As selective elimination of371
the resident GI tract microbiota may facilitate the translocation of bacteria to systemic372
organs and tissues (33) and as E. coli K1 replicates in the neonatal rat intestine373
concomitant with translocation to the blood (15), we hypothesized that K1 intestinal374
colonization prior to the acquisition of a fully developed microbiota would permit375
sufficient replication of the neuropathogen to enable translocation to take place. We376
therefore determined the qualitative and quantitative bacterial composition of GI tract377
tissues from P2, P5 and P9 animals using qPCR of conserved 16S small subunit (SSU)378
rRNA genes and a customized SSU rDNA microarray designed to detect most currently379
recognized species and taxonomic groups of bacteria; we also quantified E. coli K1 from380
GI tract whole-tissue homogenates using qPCR of the K1-specific neuS gene.381
There was a high degree of similarity, both quantitatively and qualitatively, between382
the GI tract microbiota of rat litters (Fig. 3; Fig. S1 in Online Supplemental Material); by383
P2, uninfected pups had acquired large numbers of resident bacteria and the numbers,384
expressed as CFU/g tissue, did not increase significantly over the P2-P9 period (Fig. 3A).385
Even at P2, the range of phyla representative of mammalian GI tract bacterial populations386
(34, 35) was generally present with an abundance comparable to that found in adult feces,387
although Bacteriodetes comprised a smaller proportion of the GI tract microbiota in P2-388
P9 rats compared to adult feces (Fig. 3B). The Firmicutes/Actinobacteria and389
Proteobacteria dominated bacterial populations over the period P2-P9 and there were no390
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significant (p = >0.57) differences in the abundance of these phyla in samples from these391
pups. In accord with observations in human infants (11), Bacteriodetes comprised a392
smaller proportion of the GI tract microbiota in P2-P9 rats compared to adult feces (Fig.393
3B) as a result of under-representation of Bacteroides (Fig. S1C). There were no394
significant differences between P2, P5 and P9 pups with regard to the three dominant395
phyla (Fig. S1A-C). At species level within these phyla, there were significant differences396
between pups of the three age groups for only eight species and these are described in397
Fig. S1D. Less abundant phyla included Acidobacteria, Nitrospina and Fusobacteria. It is398
noteworthy that the Acidobacteria, a recently established (36) phylum of metabolically399
versatile bacteria associated in the main with diverse environmental habitats that400
encompass soil, freshwater habitats and metal-contaminated subsurface sediments (37,401
38) and are occasionally found in gastrointestinal material (39, 40), were present in all GI402
tract samples we examined. Similarly, the chemolithoautotrophic bacteria of the phylum403
Nitrospina (Nitrospora) are generally associated with aquatic environments (41) but were404
encountered in all groups of neonatal rats. Thus, we found a high degree of comparability405
in the composition of the neonatal rat gut microbiota over the P2-P9 period and also good406
qualitative and quantitative accord between neonatal and adult GI tract bacterial407
populations.408
No significant differences were found in the capacity of E. coli A192PP to colonize409
and persist in the P2, P5 and P9 GI tract for at least five days following oral410
administration of a bacterial suspension (Fig. 3C). Immediately after feeding the E. coli411
K1 strain to both P2 and P9 animals, a major portion of the inoculum distributed to the412
lower intestine and cecum/colon over the following 48 h period (Fig. 3D). Within 24 h,413
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the largest E. coli K1 population was found in cecum/colon tissue samples. Significantly414
larger numbers of E. coli K1 were detected in the upper GI tissues of P2-inoculated415
compared to P9-inoculated neonates at all time points sampled but numbers were416
comparable in cecum/colon tissues (Fig. 3D). There was clear evidence of extensive E.417
coli K1 replication in the GI tract after introduction of strain A192PP (Fig. S2).418
419
GI tissue responses to E. coli A192PP colonization are notably different in P2 and420
P9 rat pups. In the first hours and days following birth, there is a distinct expression421
pattern of innate immune molecules by mucosal epithelia aimed at preventing infection422
whilst avoiding excessive inflammatory responses to bacteria and their products (6).423
During early postnatal development, this bias against TH1-cell-polarizing cytokine-424
mediated effects alters following exposure to microbes, diminishing TH2-cell polarization425
and enhancing TH1-cell polarization, and these effects are likely to be pronounced in gut426
tissue due to the rapid accumulation of a complex microbiota. We therefore examined the427
response of P2 pups to colonization by E. coli K1 to determine if any differences in428
response compared to P9 animals could shed light on the basis of the age dependency of429
systemic infection. P2 and P9 pups were fed strain A192PP, GI tract tissues were430
removed after 12 h and duodenum to colon samples prepared for microarray analysis.431
Arrays were performed by pooling equimolar amounts of RNA extracted from three432
infected rat pups. Responses were standardized against tissues removed at the same time433
from non-colonized animals of identical age and processed in identical fashion.434
Major differences were found in the response of P2 and P9 pups to colonization (Fig.435
4; Tables S1-S5); A total of 241 genes were up-regulated twofold or more in the P2 GI436
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tract compared to 354 in P9 animals but only 22 genes were common to both data sets.437
More genes (240) were down-regulated at least twofold in P9 compared to 36 in P2438
samples, with eight genes common to both (Fig. 4A; Table S6). With both pooled P2 and439
P9 tissue arrays, up- and down-regulated genes belonged to a wide range of functional440
categories, with genes involved in growth, differentiation and development, cell441
metabolism and transcriptional regulation strongly represented (Table S1). In both P2 and442
P9 tissues, genes encoding MHC Class I and Class II proteins were differentially443
expressed. For example, RT1-Aw2, encoding RT1 class Ib, was the most strongly up-444
regulated (17.7-fold) gene in P2-colonized GI tissues (Table S2) and RT1-A3 and RT1-445
Db1, encoding RT1Class I and Class II proteins respectively, were highly down-regulated446
in P2-colonized tissues (Table S3). In pups colonized at P9, the most prominently up-447
regulated (11.8-fold) gene was the MHC class II protein-encoding RT1-Bb gene and448
expression of RT1-Aw2 was also significantly increased (Table S4); RT1-A3 and RT1-449
Db1 were also down-regulated in P9 pups (Table S5). These and other MHC genes450
feature in the relatively short list of genes whose regulation was modulated by451
colonization in both P2 and P9 tissues, along with genes involved in mRNA splicing,452
DNA damage repair and protein modification (Table S6). A number of genes involved in453
initiation of apoptosis, such as pcdc4, stk17b, casp2 and casp3, were up-regulated in P9-454
but not P2-colonized tissues (Table S4) and genes encoding anti-apoptotic factors such as455
Tgfb2 and Hspa5 concomitantly down-regulated (Table S5) in P9 only. Also noteworthy456
was the 2.5-fold up-regulation in P9 but not P2 of DDX3X, encoding a helicase that457
together with TBK1 is central to the induction of type-1 interferons in response to458
pathogens (42).459
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A very limited number of genes whose products are likely to be directly linked to the460
susceptibility of P2 pups to post-colonization infection were differently regulated by461
colonizing E. coli K1 in P2 compared to P9 pups. The genes encoding the α-defensins462
Defa24 and Defa-rs1 were up-regulated 3.1- and 5.4-fold respectively in colonized P9,463
but not P2 pups (Table S4). This class of bactericidal peptides, produced by Paneth cells464
in the small intestine (43, 44), regulates the composition of the intestinal bacterial465
microbiome (45), control intestinal barrier penetration by commensular and pathogenic466
bacteria (46) and are necessary for antibacterial defense in the neonate (47). The failure467
of P2 animals to respond to E. coli K1 colonization in similar fashion to P9 pups may468
enhance the capacity of this neuropathogen to reach the small intestinal epithelium, as α-469
defensins are thought to limit the bacterial load at the epithelial surface (48). We470
therefore investigated temporal aspects of α-defensin gene expression in relation to471
colonization by E. coli A192PP. The most highly down-regulated gene (26.4-fold) in P2472
animals was tff2, encoding trefoil factor 2. This small peptide plays a role in GI mucosal473
protection, stabilizes the mucus layer and enhances intestinal epithelial repair (49). As the474
mucus layer continues to develop post partum in the rat (50) and the goblet cell475
complement of the P2 gut appears to be low in comparison to P9 and adult animals (Fig.476
2), we investigated the impact of tff2 down-regulation on the development of the mucus477
layer between P2 and P9.478
Microarray data were validated by qRT-PCR analysis of eleven differentially479
regulated genes from the P2 (RT1-Aw2, Btg2, Cald1, Tff2 and Ins2) and P9 (Defa-rs1,480
Pdcd4, Clic4, Cav, Afp and Amy2) datasets. A highly significant (p <0.0001) Pearson481
correlation was obtained when microarray and qRT-PCR data were compared.482
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GI tract colonization by E. coli A192PP modulates defa24 and defa-rs1 expression484
over the P2-P9 period of neonatal development. No information is available regarding485
temporal aspects of α-defensin gene expression in the rat over the neonatal period. In486
order to provide context for the modulation of defa-rs1 and defa24 by colonizing E. coli487
K1, we determined the expression of these genes in duodenum to colon GI tract tissues488
from non-colonized pups over the P1-P11 post partum period. The level of expression of489
both genes progressively increased over this period, peaking at P10; over the eleven days,490
defa-rs1 expression increased approximately twelvefold and defa24 fourfold (Fig. 4G).491
To determine the effects of colonization on these background levels of gene expression,492
P2 and P9 pups were fed E. coli A192PP and gene expression compared to same-age493
non-colonized animals 6, 12, 24 and 48 h post-colonization by semi-quantitative PCR494
(Fig. 4B). The data suggested that, in P2 animals, the expression of both genes increased495
24-48 h after E. coli K1 dosing; in P9 pups, increases in defa24 expression peaked 24h496
after dosing whereas defa-rs1 expression continued to increase over the 48 h period in497
comparison to animals fed broth rather than bacteria. As the levels of defa24 and defa-rs1498
continue to rise in control pups over this period, providing a changing background upon499
which to assess the degree of gene modulation resulting from colonization, we quantified500
levels of gene expression for both genes by qPCR and normalized the data against the501
normal developmental levels (Fig. 4G).502
Expression of defa24 in P2 gut tissues was similar to background levels following E.503
coli K1 colonization. In contrast, defa24 expression in the P9 gut was significantly504
increased up to 12 h post-colonization but returned to levels comparable to those found in505
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the control group within 24-48 h (Fig. 4D). Levels of defa-rs1 expression in colonized P2506
pups remained comparable to those found in control animals over the 48 h period507
whereas expression was increased at all time points in colonized P9 pups; differences in508
defa-rs1 expression between P2 and P9 animals was significant at all time points over509
this period (Fig. 4E). We conclude that P2 pups, in contrast to P9 rats, are unable to510
respond to E. coli A192PP colonization by up-regulation of expression of α-defensin511
peptide genes.512
513
Suppression of Tff2 in the P2 GI tract by E. coli K1 colonization. We established that514
tff2 expression in non-E. coli K1-colonized pups increased incrementally from P1 up to515
P9 but substantially declined over P9-P11 (Fig. 4G). Semi-quantitative PCR indicated516
that tff2 expression was down-regulated over the 48 h post-colonization period in P2 but517
not P9 pups (Fig. 4B); qPCR confirmed that, whereas GI tissue levels of tff2 in P9-518
colonized pups did not differ significantly over this period from the normal519
developmental levels shown in Fig. 4G, tff2 levels were markedly reduced by520
colonization at P2 (Fig. 4C). Suppression of gene expression in P2 tissues was evident at521
24-48 h; the degree of down-regulation compared to expression in P9 pups was highly522
significant and was tightly correlated with the reduced levels of Tff2 protein found in P2523
and P9 tissue homogenates (Fig. 4F).524
Transcription of tff genes is repressed by IL-1β and IL-6 (51); cell stimulation by525
these pro-inflammatory cytokines leads to release of NF-κB and C/EBPβ from resting 526
state complexes in the cytoplasm and their translocation to the nucleus (52), where they527
inhibit transcription of trefoil factor genes. We therefore assessed the systemic levels of528
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these cytokines by cytokine-specific ELISA of serum samples obtained from P2 and P9529
neonates colonized with E. coli K1 and compared these to non-colonized animals. A two-530
to threefold elevation in systemic IL-1β from levels found in non-colonized controls was531
observed 6-24 h after feeding E. coli K1 in P2-colonized but not in P9-colonized neonates532
(Fig. S2A). No IL-6 was detected in either colonized or non-colonized P2 neonates;533
although IL-6 was detected in both colonized and non-colonized P9 cohorts, no534
significant differences were observed between the experimental groups (Fig. S2B). In535
order to provide evidence for the role of NF-κB in tff2 transcriptional repression, we536
assessed the extent of NF-κB localization to intestinal cell nuclei by electrophoretic 537
mobility shift assay using a Cy5-labelled dsDNA probe containing the NF-κB consensus538
binding motif incubated with nuclear protein extracts obtained from intestinal tissues of539
neonates colonized with E. coli K1 and broth-fed, non-colonized animals (Fig. S2C).540
Although a degree of band-shift was observed in all samples, the intensity of the shifted541
band was greater in colonized, compared to non-colonized, P2 animals. A control assay542
utilizing non-labeled wild-type and mutant dsDNA competitors yielded reduced band-543
shift in the wild-type but not the mutant competition reactions, indicating that the band-544
shift was specific for the NF-κB binding motif sequence. These results suggest that E.545
coli K1 intestinal colonization provokes a significant increase in the release of IL-1β in546
P2-colonized pups, leading to increased nuclear localization of NF-κB.547
The observation that P2 pups possess fewer goblet cells than P9 rats (Fig. 2) is548
reflected in less small intestine-associated mucin and a thinner Muc2-immunostaining549
layer in the colon compared to the infection-resistant P9 neonates (Fig. 5). Less mucin550
was evident 48 h after oral feeding of E. coli K1 (Fig. 5C) compared to broth-fed pups551
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(Fig. 5B), although much of this can be accounted for by a large decrease in Muc2 stored552
in colonic goblet cells, presumably expelled into the gut lumen in response to E. coli K1553
colonization. At P4, animals are relatively susceptible to E. coli K1 infection (Fig. 1B), so554
the colonic mucin content of animals sham-fed at P2 and culled at P4 (Fig. 5B) may not555
be sufficient to afford protection against systemic infection.556
557
DISCUSSION558
The data presented here and by other workers (14, 17) provide compelling evidence that559
the capacity of E. coli K1 to translocate from the GI tract to the bloodstream constitutes560
the basis of susceptibility to systemic infection in the neonatal rat model. It is generally561
accepted that the gut microbiota confers colonization resistance, prohibiting both562
potentially harmful (53, 54) and potentially beneficial (55) microbes from establishing a563
foothold in the GI tract. This protective role is complemented by the capacity of members564
of the microbiota to modulate the virulence of some opportunistic pathogens (56, 57). We565
therefore hypothesized that the gut microbiota of susceptible P2 pups was likely to be less566
well developed than that of resistant P9 rats and would permit colonizing E. coli K1 to567
reach sufficient numbers in the GI tract to allow transit to the blood; colonial expansion568
would be denied to E. coli K1 in the P9 GI tract.569
In broad terms, this hypothesis is not supported by our data. Although the intestinal570
microbiota of P2, P5 and P9 pups were quantitatively and qualitatively different from the571
adult microbiota, they were remarkably similar to each other. Even two days post partum572
a highly complex bacterial consortium had developed in the GI tract that was barely573
distinguishable from that found in P9 animals. However, the methods used in this574
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investigation do not take into account spatial aspects of the distribution of the microbial575
population. The individual GI compartments have distinct biochemical and physical576
properties and represent diverse ecological niches. Accordingly, the gastric, small577
intestinal and colonic compartments play host to a partially distinct subset of the GI578
microbiota (58, 59, 60) and it is possible that significant changes to the microbiota of579
these regions occur over the P2-P9 period in a way that could influence susceptibility to580
infection.581
The microbiota appeared to exert little influence on the capacity of E. coli A192PP to582
stably colonize the GI tract of P2-P9 pups, notwithstanding that the strain was selected583
for this study on the basis of its systemic virulence following GI tract colonization. No584
differences in the E. coli K1 burden after colonization at P2, P5 or P9 could be585
demonstrated after 120 h and the temporal development of the K1 population was very586
similar in these age groups. We did, however, note some significant differences in the587
temporal and spatial distribution of E. coli A192PP along the GI tract that almost588
certainly relate to differences in innate competence between P2 and P9 pups, lending589
support to the contention that the bacteria are more likely to translocate from the small590
intestine than the colon. The stabilization of the E. coli K1 intestinal load 24 h after591
colonization indicates that there may be an upper limit to the size or growth capacity of592
the bacterium in the neonatal intestine. The population climaxed immediately prior to the593
bacterial translocation window, suggesting that a critical E. coli K1 population density594
must be reached before translocation to the blood compartment can occur.595
The intestinal tissues are subject to significant post partum development in response596
to exposure to the extra-uterine environment and the initiation of enteral feeding.597
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Changes include the proliferation of two secretory epithelial cell lineages which play a598
key role in maintaining intestinal barrier function in the small intestinal and colonic599
compartments. The colonic goblet cell population continues to expand post partum and is600
accompanied by increased production of Muc2 and trefoil peptides (61, 62). The small601
intestinal Paneth cell population also proliferates rapidly in the postnatal period (63), as602
does their secretion of antimicrobial peptides (64). The proteins secreted by these cells603
are vital for maintaining the microbiota away from the enteric epithelial surface (65, 66).604
The fact that they are developmentally regulated indicates that the intestinal barrier605
function in younger neonates is immature and partly informed our view that the606
development of the neonatal intestine over the P2-P9 period modulates susceptibility to607
E. coli K1 systemic infection.608
The neonatal intestinal tract grew substantially over the P2-P9 period and was609
accompanied by a significant degree of developmental gene regulation. Based on our610
observations and the current state of knowledge regarding the developmental regulation611
of Paneth (40) and goblet cells (67), we propose a model to account for the development612
of innate defense barriers in the neonatal rat intestine over the P2-P9 period (Fig. 6).613
Thus, at P2 the ileum secretes lower quantities of α-defensins and the colon lower614
quantities of Muc2 and trefoil factor than at P9, resulting in an underdeveloped stratified615
inner mucus layer in comparison to P9 pups that permits closer association between the616
intestinal microbiota (which inhabit the outer mucus layer) and the intestinal epithelium.617
The comparative lack of α-defensin expression in P2 tissues indicates that the618
antimicrobial peptide-dependent barrier function of the small intestine is weaker at P2619
compared to P9 and is likely to be a factor that determines the differences in E. coli620
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A192PP numbers along the GI tract. In future work, we will examine the possibility that621
defects in α-defensin-mediated barrier function allow K1 colonizers to penetrate622
enterocytes in P2 pups. The development of the colonic mucus barrier may be related to623
the transient increase in Tff2 expression from P2-P9. Expression of Tff3 in the rat colon624
does not start to increase towards adult levels until P12-P17 (58, 68); given the apparent625
role of Tff3 as a structural component of the colonic mucus barrier (69), this pattern of626
developmental expression seems unusual. Tff2 may play a similar role to Tff3 in the early627
neonatal intestine, stabilizing the developing colonic mucus barrier prior to the628
developmental increase in Tff3 expression, or it may be localized to the small intestine629
rather than the colon.630
The transcriptional responses of P2 and P9 intestinal tissues to colonization by E. coli631
K1 were highly divergent. Several genes encoding products involved in host defense632
were differentially expressed, including developmentally regulated α-defensins and Tff2.633
There were comparatively few differentially expressed genes shared between colonized634
P2 and P9 neonates, indicating that the intestinal tissue of the refractive neonate responds635
very differently to that of the susceptible neonate and may in part determine susceptibility636
to systemic infection. Suppression of Tff2 with concomitant loss of Muc2 in P2-637
colonized tissues may allow E. coli K1 to gain access to the intestinal epithelium.638
Conversely, the up-regulation of α-defensins by P9-colonized tissues may prevent this639
interaction. Thus, we propose (Fig. 6) that in P2 animals, the relative deficiency of α-640
defensins allows the pathogen to access and invade the tissues of the small intestine [1];641
bacterial colonization is detected by intestinal leucocytes [2]; activated leucocytes secrete642
IL-1β, which activates NF-κB transcription factor [3]; activated NF-κB suppresses trefoil 643
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factor in goblet cells with concomitant breakdown of the inner mucus layer structure [4],644
allowing bacteria to access and invade colonic tissue [5]. In P9 pups, up-regulation of α-645
defensins denies the bacteria access to tissues of the small intestine [1] and prevents IL-646
1β secretion by leucocytes [2]; a thick and intact inner mucus layer prevents bacterial647
access to colonic tissue [3]. In all likelihood, the mucus layer keeps the colonizing648
bacteria away from the gut wall, preventing interactions with the epithelial surface.649
Evidence that E. coli K1 cells gain access to the enterocytes in susceptible pups will650
provide strong support for this model and such interactions will be sought using651
immunohistochemical procedures. The model would be further strengthened by652
demonstration that E. coli K1 colonization of α-defensin knockout rats at P9 induces the653
bacteremic state and we are actively pursuing this line of investigation.654
E. coli K1 colonization of the P2 intestine invariably results in translocation of the655
pathogen from the intestine into the systemic circulation. The site or sites of translocation656
have yet to be resolved and the proximal small intestine is a likely candidate. However,657
developmental deficits appear to be present in the P2 small intestinal and colonic barriers658
and consequently both regions represent a potential route of invasion. Lack of secreted α-659
defensins could allow E. coli K1 to access the small intestinal epithelium. Alternatively,660
dysregulation of Tff2 expression may provide access to the colonic epithelium. We have661
provided some indication that tff2 transcriptional repression involves IL-1β and NF-κB. 662
Colonization of the P2 intestine induces the secretion of IL-1β into the systemic663
circulation, but this could be due to the early presence of bacteria in the blood; we664
therefore plan to examine cytokine levels in tissues in more detail in order to provide a665
mechanistic basis for susceptibility to infection. This is most likely due to the detection of666
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PAMPs by the intestinal leukocyte population. Adult intestinal macrophages lack the667
CD14 receptor which systemic macrophages use to detect bacterial lipopolysaccharide668
(70). Lipopolysaccharide tolerance prevents intestinal macrophages from inducing669
potentially damaging inflammatory reactions in response to the intestinal microbiota;670
tolerance does not develop until the perinatal period (71, 72) and may explain why IL-1β671
secretion is not induced in P9 neonates. Further, α-defensins represent another potential672
inhibitor of IL-1β secretion from macrophages in the P9 intestine (73).673
E. coli K1 colonization at P2 may suppress Muc2 synthesis or induce goblet cells to674
expel stored Muc2 into the intestinal lumen in an attempt to clear the pathogen from the675
intestine, an effect that has been observed following colonization by the rodent intestinal676
pathogen Citrobacter rodentium (74, 75). The loss of stored Muc2 at such an early stage677
in the development of the colonic mucus barrier could compromise developmental678
processes and provide a possible route of infection for E. coli K1.679
680
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936
FIG 1. Age-dependent susceptibility of the neonatal rat to systemic E. coli K1 infection.937
(A) GI tract colonization, bacteremia and accumulated deaths of neonatal rat pups fed E.938
coli A192PP two (P2), five (P5) and nine (P9) days after birth. All pups in a litter939
received the oral dose on day 0. Colonies expressing the K1 capsule were detected using940
K1-specific bacteriophage from perianal swab cultures and from blood samples. Data941
shown are from representative experiments involving single litters of 9-14 pups. (B)942
Survival of P2-P9 rat pups fed E. coli A192PP. Two litters (12 pups per litter) of two- to943
nine-day-old pups were used for each time point and the animals monitored for a period944
of one week following oral dosing of bacterial cultures; n=24, ± 1SD. (C) Gross945
morphological appearance of GI tract tissue (stomach to colon) from P1-P9 rat pups.946
947
FIG 2. Rapid development of GI tract tissue morphology during the early postnatal948
period. Small intestinal (SI) and colonic tissues from P2 and P9 animals were fixed,949
sectioned and stained with Alcian blue/PAS. The scale bar is 100 µm.950
951
FIG 3. Comparable rates of GI tract colonization by E. coli A192PP over P2-P9 neonatal952
period complements rapid development of the GI tract microbiota in neonatal rats. (A)953
Bacterial load, determined by qPCR of conserved 16S SSU rRNA genes, of GI tract954
tissues and fecal content from P2, P5 and P9 rat pups. At each time point, four animals955
from each of three litters were sampled. (B) Relative abundance of bacterial phyla of the956
GI microbiota by SSU rDNA microarray. Data normalized to adult data as indicated by957
43
dashed line at x=1. Four litters were employed. Four animals removed from each litter at958
P2, P5 and P9; bacterial DNA extracted from tissue samples at each time point hybridized959
with DNA from the appropriate maternal fecal sample. Results from each of four litters960
were combined. Probes ranked according to average Cy5 and Cy3 fluorescence, with the961
highest at the top of each figure. (C) Temporal aspects of E. coli K1 GI tract colonization962
of P2, P5 and P9 animals. K1 bacteria were quantified by qPCR of the neuS gene. DNA963
extracted from GI tissues and their contents and a calibration curve constructed to convert964
data to CFU. Two litters of neonatal rats were employed. Four animals were removed965
from each litter at each time point, the GI tissue removed and processed and DNA966
representing each time point pooled. LOD: limit of detection. (D) Colonization of the967
proximal small intestine, distal small intestine and cecum/colon over the 48 h period968
following feeding of E. coli A192PP to P2 and P9 pups. E. coli K1 bacteria were969
quantified by qPCR with the neuS probe. Data normalized to tissue mass following970
conversion to CFUs. Error bars represent the SEM from n=4 animals. Significant971
differences, as determined by 2-tailed Mann-Whitney test: * p<0.05, ** p<0.01, ***972
p<0.001.973
974
FIG 4. P2 and P9 host responses to E. coli K1 intestinal colonization. (A) P2 and P9975
intestinal tissues show differential transcriptomic responses to E. coli K1 colonization as976
demonstrated by comparison of microarray analysis of RNA extracted from colonized977
and non-colonized P2 and P9 tissues 12 h post-inoculation with E. coli K1 or broth; n=4.978
(B) Expression of tff2, defa24, defa-rs1 and the reference gene rps23 were analyzed by979
semi-quantitative RT-PCR followed by resolution of pooled cDNA amplicons on agarose980
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gels, and by quantitative qRT-PCR analysis (C, D and E) of RNA extracted from GI tract981
tissues from colonized and non-colonized P2 and P9 animals 6, 12, 24 and 48 h post-982
inoculation with E. coli K1 or broth. Data from colonized animals were normalized to983
data from an equal number of non-colonized (broth-fed) animals. Tff2 protein was984
quantified by competitive ELISA of protein extractions from colonized and non-985
colonized animals (F). The normal developmental expression of tff2, defa24, and defa-rs1986
over the P1-P11 period was examined by normalizing qRT-PCR data from non-colonized987
animals to data obtained from RNA extracted from non-colonized P1 neonatal intestinal988
tissues (G). Error bars for all figures represent the SEM of results from either n=12 (C, D989
and E) or n=6 (F) animals. Statistically significant differences, as determined by 2-tailed990
t-test, between colonized and non-colonized animals are indicated (* p<0.05, ** p<0.01,991
*** p<0.001).992
993
FIG 5. E. coli K1 colonization of P2 pups results in depletion of Muc2 mucin from994
colonic epithelial cells. Anti-Muc2 immunostaining of sections of colonic tissues from P2995
(A-C) and P9 (D-F) neonatal rats. Tissues were obtained at P2 (A) or P9 (D) and at 48 h996
after feeding neonates a control dose (B, E) or E. coli A192PP (C, F). The epithelial997
surface (green line), lumen (L) and stratified mucus layer (white line) are indicated where998
appropriate. The scale bar is 100 µm.999
1000
FIG 6. Proposed model of GI barrier development in rats from P2 (A) to P9 (B).1001
Colonization of the P2 (C) and P9 (D) GI tract by E. coli K1. The numbered steps in C1002
and D are expanded in the text.1003
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